Amidst all the great news, I would think it'd be fair to suggest that feedback from FDA will be that a larger sample size is needed than just 10 participants?Not to dampen spirits, I'm as excited as anyone, but I would think that makes sense? Is there any precedent for otherwise being able to go to market?